UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD

Respiratory medicine, 2013-10, Vol.107 (10), p.1538-1546

2013

Volltextzugriff (PDF)

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

International journal of chronic obstructive pulmonary disease, 2017-01, Vol.12, p.745-755

2017

Volltextzugriff (PDF)

Analyse comparative en sous-groupe de umeclidinium/vilanterol vs. tiotropium chez des patients BPCO

Revue des maladies respiratoires, 2017-01, Vol.34, p.A150-A150

2017

Volltextzugriff (PDF)

Escalade thérapeutique du tiotropium à UMEC/VI chez des patients BPCO modérés symptomatiques : étude randomisée de 12 semaines

Revue des maladies respiratoires, 2017-01, Vol.34, p.A172-A173

2017

Volltextzugriff (PDF)

Asymmetric catalytic routes to chiral building blocks of medicinal interest

Pure and applied chemistry, 1996-01, Vol.68 (1), p.37-44

1996

Volltextzugriff (PDF)

Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis

Annals of allergy, asthma, & immunology, 2004-02, Vol.92 (2), p.201-207

2004

Volltextzugriff (PDF)

Wirkungseintritt von Umeclidinium/Vilanterol im Vergleich zu anderen Erhaltungstherapien bei Patienten mit COPD

Pneumologie (Stuttgart, Germany), 2016, Vol.70 (S 01)

2016

Volltextzugriff (PDF)

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Umec/vi As Step-Up Therapy From Tiotropium In Moderate Symptomatic COPD: A Randomized, 12-Week Study

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

B104 IT'S NO LONGER A SECRET SERVICE: UPDATES IN COPD PHARMACOTHERAPY: Bronchodilator Response To The Long-Acting Bronchodilator Combination Of Umeclidinium/vilanterol Across Subgroups Of Patients With COPD

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD

Pulmonary pharmacology & therapeutics, 2005-01, Vol.18 (1), p.19-22

2005

Volltextzugriff (PDF)

Physiological and pharmacological comparisons of angiotensin II receptors in neuronal and astrocyte glial cultures

Progress in neurobiology, 1990, Vol.34 (5), p.355-385

1990

Volltextzugriff (PDF)

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Onset Of Effect Of Umeclidinium/vilanterol Compared With Other Maintenance Therapies In Patients With COPD

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

Journal of allergy and clinical immunology, 2001-05, Vol.107 (5), p.783-789

2001

Volltextzugriff (PDF)

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial

Journal of allergy and clinical immunology, 2001-03, Vol.107 (3), p.461-468

2001

Volltextzugriff (PDF)

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

Journal of allergy and clinical immunology, 2000-06, Vol.105 (6), p.1123-1129

2000

Volltextzugriff (PDF)

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma

Annals of allergy, asthma, & immunology, 1999-04, Vol.82 (4), p.383-389

1999

Volltextzugriff (PDF)

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

Journal of allergy and clinical immunology, 1999-06, Vol.103 (6), p.1075-1080

1999

Volltextzugriff (PDF)

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study

Clinical therapeutics, 2005-05, Vol.27 (5), p.531-542

2005

Volltextzugriff (PDF)

Sozialpaedagogen im Beruf: Trendbericht einer regionalen Erhebung zur beruflichen Entwicklung und Situation von Diplompaedagogen, Sozialpaedagogen und Sozialarbeitern. Zwischenbericht (September 1980). Expertise zum Symposium "Berufsfeld Sozialpaedagogik/Sozialarbeit"

1980

Volltextzugriff (PDF)

Rh−DuPHOS-Catalyzed Enantioselective Hydrogenation of Enol Esters. Application to the Synthesis of Highly Enantioenriched α-Hydroxy Esters and 1,2-Diols

Journal of the American Chemical Society, 1998-05, Vol.120 (18), p.4345-4353

1998

Volltextzugriff (PDF)

Adrenergic and calcium-mediated subcellular redistribution of protein kinase C in primary neuronal cultures

Biochemical and biophysical research communications, 1990-01, Vol.166 (1), p.22-28

1990

Volltextzugriff (PDF)

Norepinephrine metabolism in neuronal cultures is increased by angiotensin II

American Journal of Physiology: Cell Physiology, 1987-06, Vol.252 (6), p.C650-C656

1987

Volltextzugriff (PDF)

295 The impact of salmeterol versus albuterol on disease specific quality of life in mild to moderate asthmatics

Journal of allergy and clinical immunology, 1996, Vol.97 (1), p.256-256

1996

Volltextzugriff (PDF)

293 Asthma-specific quality of life in patients treated with salmeterol or albuterol

Journal of allergy and clinical immunology, 1996, Vol.97 (1), p.256-256

1996

Volltextzugriff (PDF)

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

American journal of respiratory and critical care medicine, 2001-09, Vol.164 (5), p.759-763

2001

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD

Umeclidinium/vilanterol as step-up therapy from tiotropium in patients with moderate COPD: a randomized, parallel-group, 12-week study

Analyse comparative en sous-groupe de umeclidinium/vilanterol vs. tiotropium chez des patients BPCO

Escalade thérapeutique du tiotropium à UMEC/VI chez des patients BPCO modérés symptomatiques : étude randomisée de 12 semaines

Asymmetric catalytic routes to chiral building blocks of medicinal interest

Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis

Wirkungseintritt von Umeclidinium/Vilanterol im Vergleich zu anderen Erhaltungstherapien bei Patienten mit COPD

D36 COPD: LABA, LAMA, ICS, AND COMBINATIONS: Umec/vi As Step-Up Therapy From Tiotropium In Moderate Symptomatic COPD: A Randomized, 12-Week Study

B104 IT'S NO LONGER A SECRET SERVICE: UPDATES IN COPD PHARMACOTHERAPY: Bronchodilator Response To The Long-Acting Bronchodilator Combination Of Umeclidinium/vilanterol Across Subgroups Of Patients With COPD

The bronchodilator response to salmeterol is maintained with regular, long-term use in patients with COPD

Physiological and pharmacological comparisons of angiotensin II receptors in neuronal and astrocyte glial cultures

D36 ALL TOGETHER NOW: COPD TREATMENT WITH LONG-ACTING BETA AGONISTS AND LONG-ACTING MUSCARINIC ANTAGONISTS: Onset Of Effect Of Umeclidinium/vilanterol Compared With Other Maintenance Therapies In Patients With COPD

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: An eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study

Sozialpaedagogen im Beruf: Trendbericht einer regionalen Erhebung zur beruflichen Entwicklung und Situation von Diplompaedagogen, Sozialpaedagogen und Sozialarbeitern. Zwischenbericht (September 1980). Expertise zum Symposium "Berufsfeld Sozialpaedagogik/Sozialarbeit"

Rh−DuPHOS-Catalyzed Enantioselective Hydrogenation of Enol Esters. Application to the Synthesis of Highly Enantioenriched α-Hydroxy Esters and 1,2-Diols

Adrenergic and calcium-mediated subcellular redistribution of protein kinase C in primary neuronal cultures

Norepinephrine metabolism in neuronal cultures is increased by angiotensin II

295 The impact of salmeterol versus albuterol on disease specific quality of life in mild to moderate asthmatics

293 Asthma-specific quality of life in patients treated with salmeterol or albuterol

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

Suchergebnisse filtern